Heska Corp. of Loveland, Colo., has entered into an agreement with Roche Diagnostics Corp. for the supply of blood gas products and affiliated consumables for the veterinary market.
“Heska and Roche share the same passion for innovating in the field of advanced point-of-care diagnostics,” said Michael McGinley, president and chief operating officer of Heska. “Because Roche is a global leader in diagnostics for the human market, we cannot imagine a better partner to further our commitment to advanced solutions to the veterinary community.”
Roche Diagnostics is headquartered in Basel, Switzerland. Genetech, United States, is a wholly owned member of the Roche Group.